Table 3.
Chimerism in BN recipients 30 and 100 days after transplantation of LEW organs or leukocyte suspensions under a short course of tacrolimusa
30 Days |
100 Days |
|||||
---|---|---|---|---|---|---|
Flow cytometry (class I)b | Immunohistochemistry (class II)c | Lineage | Immunocytochemistry (class II)e | Tolerance | GVHD | |
Small bowel | 4.0±2.3%d | + + + | T > Me | — | No | 100% |
Lymph nodes | 4.1±1.8% | + + + | T > M | — | No | 100% |
Spleen | 7.5±0.2% | + + + | T > M | — | Minimalf | 100% |
Liver | <1.0% | + + | M = T | ± | Yes | 0 |
Bone marrow | 0 | + | M > T | ± | Yes | 0 |
Heart | 0 | ± | — | − | Partialg | 0 |
Kidney | NT | ± | — | − | NT | 0 |
Thymus | NT | − | — | − | No | 0 |
Blood | NT | − | — | − | No | 0 |
1.0 mg/kg/day on days 0 to 13; 20, and 27.
McAb 163, blood samples, or recipient lymph node suspensions.
L-21-6Ab, spleen, and cervical lymph nodes.
Mean ± SD.
NT: not tested; M: multilineage; T: T lymphocyte.
Delayed acute rejection.
Chronic rejection.